Collaborative Care for Post-Traumatic Epilepsy
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Research on similar collaborative care models, like the Trauma Collaborative Care program, shows that integrating care for emotional and psychological needs can improve outcomes for trauma patients, suggesting that a similar approach might benefit those with post-traumatic epilepsy. Additionally, integrated care models have been effective in increasing access and engagement in psychiatric care for veterans with PTSD and mild traumatic brain injury, indicating potential benefits for coordinated care in neurological conditions.
12345The research does not provide specific safety data for Collaborative Care for Post-Traumatic Epilepsy, but a study on levetiracetam, a medication used in epilepsy care, found it to be safe and well-tolerated in children with traumatic brain injury, with common side effects being headache, fatigue, drowsiness, and irritability.
678910The Neurology Based Collaborative Care treatment is unique because it involves a team of professionals from different fields, such as neurology, psychiatry, and social work, working together to provide personalized care for patients with complex needs, unlike traditional treatments that may not integrate such diverse expertise.
1112131415Eligibility Criteria
This trial is for adults with post-traumatic epilepsy who have had a traumatic brain injury and are experiencing anxiety or depression. They must be getting care at one of the study sites, agree to follow the study rules, and not be in another treatment study. People with unstable substance abuse, severe other illnesses, cognitive issues affecting survey completion, psychiatric treatment, or serious suicidal thoughts can't join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 24-week neurology-based collaborative care program or usual neurology care
Follow-up
Participants are monitored for safety and effectiveness after treatment